Research progress on spread through air spaces in lung cancer
-
摘要: 目前, 肺癌经气腔播散(STAS)的发生机制仍不明确。本研究对近年来关于STAS发生机制、诊断方式、预后影响、治疗方案选择的最新成果予以综述,为临床医生、研究人员快速了解相关研究进展以及为该领域的未来研究提供导向参考。Abstract: At present, the mechanism of spread through air spaces (STAS) in lung cancer is still unclear. In this study, the latest achievements on the pathogenesis, diagnostic methods, prognostic impact and treatment options of STAS in the past few years were reviewed, so as to provide guidance and reference for clinicians and researchers, and to quickly understand the relevant research progress and future researches in this field.
-
-
[1] BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2018, 68(6): 394-424. doi: 10.3322/caac.21492
[2] WARTH A, MULEY T, MEISTER M, et al. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival [J]. J Clin Oncol, 2012, 30(13): 1438-1446. doi: 10.1200/JCO.2011.37.2185
[3] TRAVIS W D, BRAMBILLA E, NICHOLSON A G, et al. The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification [J]. J Thorac Oncol, 2015, 10(9): 1243-1260. doi: 10.1097/JTO.0000000000000630
[4] URUGA H, FUJII T, FUJIMORI S, et al. Semiquantitative Assessment of Tumor Spread through Air Spaces (STAS) in Early-Stage Lung Adenocarcinomas [J]. J Thorac Oncol, 2017, 12(7): 1046-1051. doi: 10.1016/j.jtho.2017.03.019
[5] LEE J S, KIM E K, KIM M, et al. Genetic and clinicopathologic characteristics of lung adenocarcinoma with tumor spread through air spaces[J]. Lung cancer, 2018, 123: 121-126. doi: 10.1016/j.lungcan.2018.07.020
[6] PELOSI G, NESA F, TAIETTI D, et al. Spread of hyperplastic pulmonary neuroendocrine cells into air spaces (S. H. I. P. M. E. N. T. S): A proof for artifact [J]. Lung Cancer, 2019, 137: 43-47. doi: 10.1016/j.lungcan.2019.09.006
[7] METOVIC J, FALCO E C, VISSIO E, et al. Gross specimen handling procedures do not impact the occurrence of spread through air spaces (STAS) in lung cancer[J]. Am J Surg Pathol, 2021, 45(2): 215-222. doi: 10.1097/PAS.0000000000001642
[8] LIU A, SUN X, XU J, et al. Relevance and prognostic ability of Twist, Slug and tumor spread through air spaces in lung adenocarcinoma[J]. Cancer Med, 2020, 9(6): 1986-1998. doi: 10.1002/cam4.2858
[9] IKEDA T, KADOTA K, YOSHIDA C, et al. The epithelial-mesenchymal transition phenotype is associated with the frequency of tumor spread through air spaces (STAS) and a High risk of recurrence after resection of lung carcinoma [J]. Lung Cancer, 2021, 153: 49-55. doi: 10.1016/j.lungcan.2021.01.004
[10] YOSHIMOTO T, MATSUBARA D, SODA M, et al. Mucin 21 is a key molecule involved in the incohesive growth pattern in lung adenocarcinoma[J]. Cancer Sci, 2019, 110(9): 3006-3011. doi: 10.1111/cas.14129
[11] JIA M, YU S L, YU J Q, et al. Comprehensive analysis of spread through air spaces in lung adenocarcinoma and squamous cell carcinoma using the 8th edition AJCC/UICC staging system[J]. BMC Cancer, 2020, 20(1): 705. https://pubmed.ncbi.nlm.nih.gov/32727513/
[12] QIU X, CHEN D L, LIU Y Y, et al. Relationship between stromal cells and tumor spread through air spaces in lung adenocarcinoma[J]. Thorac Cancer, 2019, 10(2): 256-267. doi: 10.1111/1759-7714.12945
[13] YOSHIDA C, KADOTA K, IKEDA T, et al. Tumor-associated macrophage infiltration is associated with a higher rate of tumor spread through air spaces in resected lung adenocarcinomas[J]. Lung Cancer, 2021, 158: 91-96. doi: 10.1016/j.lungcan.2021.06.009
[14] KIM S K, KIM T J, CHUNG M J, et al. Lung adenocarcinoma: CT features associated with spread through air spaces[J]. Radiology, 2018, 289(3): 831-840. doi: 10.1148/radiol.2018180431
[15] DE MARGERIE-MELLON C, ONKEN A, HEIDINGER B H, et al. CT manifestations of tumor spread through airspaces in pulmonary adenocarcinomas presenting as subsolid nodules[J]. J Thorac Imaging, 2018, 33(6): 402-408. doi: 10.1097/RTI.0000000000000344
[16] TOYOKAWA G, YAMADA Y, TAGAWA T, et al. Computed tomography features of resected lung adenocarcinomas with spread through air spaces[J]. J Thorac Cardiovasc Surg, 2018, 156(4): 1670-1676, e4. doi: 10.1016/j.jtcvs.2018.04.126
[17] JIANG C S, LUO Y, YUAN J L, et al. CT-based radiomics and machine learning to predict spread through air space in lung adenocarcinoma[J]. Eur Radiol, 2020, 30(7): 4050-4057. doi: 10.1007/s00330-020-06694-z
[18] CHEN D L, SHE Y L, WANG T T, et al. Radiomics-based prediction for tumour spread through air spaces in stage I lung adenocarcinoma using machine learning[J]. Eur J Cardiothorac Surg, 2020, 58(1): 51-58. doi: 10.1093/ejcts/ezaa011
[19] WALTS A E, MARCHEVSKY A M. Current evidence does not warrant frozen section evaluation for the presence of tumor spread through alveolar spaces[J]. Arch Pathol Lab Med, 2018, 142(1): 59-63. doi: 10.5858/arpa.2016-0635-OA
[20] KIMURA T, NAKAMURA H, OMURA A, et al. Novel imprint cytological classification is correlated with tumor spread through air spaces in lung adenocarcinoma[J]. Lung Cancer, 2020, 148: 62-68. doi: 10.1016/j.lungcan.2020.08.005
[21] VILLALBA J A, SHIH A R, SAYO T M S, et al. Accuracy and reproducibility of intraoperative assessment on tumor spread through air spaces in stage 1 lung adenocarcinomas[J]. J Thorac Oncol, 2021, 16(4): 619-629. doi: 10.1016/j.jtho.2020.12.005
[22] MEDINA M A, ONKEN A M, DE MARGERIE-MELLON C, et al. Preoperative bronchial cytology for the assessment of tumor spread through air spaces in lung adenocarcinoma resection specimens[J]. Cancer Cytopathol, 2020, 128(4): 278-286. doi: 10.1002/cncy.22243
[23] MASAI K, SAKURAI H, SUKEDA A, et al. Prognostic impact of margin distance and tumor spread through air spaces in limited resection for primary lung cancer[J]. J Thorac Oncol, 2017, 12(12): 1788-1797. doi: 10.1016/j.jtho.2017.08.015
[24] SHIONO S, ENDO M, SUZUKI K, et al. Spread through air spaces is a prognostic factor in sublobar resection of non-small cell lung cancer[J]. Ann Thorac Surg, 2018, 106(2): 354-360. doi: 10.1016/j.athoracsur.2018.02.076
[25] TOYOKAWA G, YAMADA Y, TAGAWA T, et al. Significance of spread through air spaces in early-stage lung adenocarcinomas undergoing limited resection[J]. Thorac Cancer, 2018, 9(10): 1255-1261. doi: 10.1111/1759-7714.12828
[26] EGUCHI T, KAMEDA K, LU S H, et al. Lobectomy is associated with better outcomes than sublobar resection in spread through air spaces (STAS)-positive T1 lung adenocarcinoma: a propensity score-matched analysis[J]. J Thorac Oncol, 2019, 14(1): 87-98. doi: 10.1016/j.jtho.2018.09.005
[27] KADOTA K, KUSHIDA Y, KAGAWA S, et al. Limited resection is associated with a higher risk of locoregional recurrence than lobectomy in stage I lung adenocarcinoma with tumor spread through air spaces[J]. Am J Surg Pathol, 2019, 43(8): 1033-1041. doi: 10.1097/PAS.0000000000001285
[28] REN Y J, XIE H K, DAI C Y, et al. Prognostic impact of tumor spread through air spaces in sublobar resection for 1A lung adenocarcinoma patients[J]. Ann Surg Oncol, 2019, 26(6): 1901-1908. doi: 10.1245/s10434-019-07296-w
[29] CHAE M, JEON J H, CHUNG J H, et al. Prognostic significance of tumor spread through air spaces in patients with stage IA part-solid lung adenocarcinoma after sublobar resection[J]. Lung Cancer, 2021, 152: 21-26. doi: 10.1016/j.lungcan.2020.12.001
[30] TOYOKAWA G, YAMADA Y, TAGAWA T, et al. Significance of spread through air spaces in resected lung adenocarcinomas with lymph node metastasis[J]. Clin Lung Cancer, 2018, 19(5): 395-400, e1. doi: 10.1016/j.cllc.2018.04.002
[31] SUH J W, JEONG Y H, CHO A, et al. Stepwise flowchart for decision making on sublobar resection through the estimation of spread through air space in early stage lung cancer1[J]. Lung Cancer, 2020, 142: 28-33. doi: 10.1016/j.lungcan.2020.02.001
[32] DAI C Y, XIE H K, SU H, et al. Tumor spread through air spaces affects the recurrence and overall survival in patients with lung adenocarcinoma >2 to 3 cm[J]. J Thorac Oncol, 2017, 12(7): 1052-1060. doi: 10.1016/j.jtho.2017.03.020
[33] LEE J S, KIM E K, KIM M, et al. Genetic and clinicopathologic characteristics of lung adenocarcinoma with tumor spread through air spaces[J]. Lung Cancer, 2018, 123: 121-126. doi: 10.1016/j.lungcan.2018.07.020
[34] LEE M A, KANG J, LEE H Y, et al. Spread through air spaces (STAS) in invasive mucinous adenocarcinoma of the lung: Incidence, prognostic impact, and prediction based on clinicoradiologic factors[J]. Thorac Cancer, 2020, 11(11): 3145-3154. doi: 10.1111/1759-7714.13632
[35] ZHONG Y F, XU Y, DENG J J, et al. Prognostic impact of tumour spread through air space in radiological subsolid and pure solid lung adenocarcinoma[J]. Eur J Cardiothorac Surg, 2021, 59(3): 624-632. doi: 10.1093/ejcts/ezaa361
[36] LU S H, TAN K S, KADOTA K, et al. Spread through air spaces (STAS) is an independent predictor of recurrence and lung cancer-specific death in squamous cell carcinoma[J]. J Thorac Oncol, 2017, 12(2): 223-234. doi: 10.1016/j.jtho.2016.09.129
[37] KADOTA K, KUSHIDA Y, KATSUKI N, et al. Tumor spread through air spaces is an independent predictor of recurrence-free survival in patients with resected lung squamous cell carcinoma[J]. Am J Surg Pathol, 2017, 41(8): 1077-1086. doi: 10.1097/PAS.0000000000000872
[38] YANAGAWA N, SHIONO S, ENDO M, et al. Tumor spread through air spaces is a useful predictor of recurrence and prognosis in stage I lung squamous cell carcinoma, but not in stage II and III[J]. Lung Cancer, 2018, 120: 14-21. doi: 10.1016/j.lungcan.2018.03.018
[39] ALY R G, REKHTMAN N, LI X Y, et al. Spread through air spaces (STAS) is prognostic in atypical carcinoid, large cell neuroendocrine carcinoma, and small cell carcinoma of the lung[J]. J Thorac Oncol, 2019, 14(9): 1583-1593. doi: 10.1016/j.jtho.2019.05.009
[40] ALTINAY S, METOVIC J, MASSA F, et al. Spread through air spaces (STAS) is a predictor of poor outcome in atypical carcinoids of the lung[J]. Virchows Arch, 2019, 475(3): 325-334. doi: 10.1007/s00428-019-02596-8
[41] YOKOYAMA S, MURAKAMI T, TAO H, et al. Tumor spread through air spaces identifies a distinct subgroup with poor prognosis in surgically resected lung pleomorphic carcinoma[J]. Chest, 2018, 154(4): 838-847. doi: 10.1016/j.chest.2018.06.007
[42] TAKEDA-MIYATA N, KONISHI E, TANAKA T, et al. Prognostic significance of spread through air spaces in pulmonary metastases from colorectal cancer[J]. Lung Cancer, 2020, 149: 61-67. doi: 10.1016/j.lungcan.2020.09.010
[43] LIU A, HOU F, QIN Y, et al. Predictive value of a prognostic model based on pathologic features in lung invasive adenocarcinoma[J]. Lung Cancer, 2019, 131: 14-22. doi: 10.1016/j.lungcan.2019.03.002
-
期刊类型引用(9)
1. 周柯,徐建欣,邢国征. 尿常规检验中常用四项指标用于老年高血压诊断的效果分析. 婚育与健康. 2024(06): 49-51 . 百度学术
2. 吴卫林,杨波,钱江远,邹志勇,万美珍,陈丽萍. 依那普利叶酸片联合硝苯地平控释片对高血压患者血压及同型半胱氨酸水平的影响. 中国医学创新. 2023(09): 61-64 . 百度学术
3. 黄辉民,李以平,夏艳春. 右美托咪定复合阿芬太尼在老年高血压患者内镜逆行性胰胆管造影术中的临床效果及对氧化应激的影响. 中国当代医药. 2023(18): 122-125+130 . 百度学术
4. 朱明明,李宗虎,郑宪玲,王颖霞,张树杰. 2型糖尿病患者血糖波动与血清网膜素-1及氧化应激因子的关系. 实用临床医药杂志. 2023(20): 113-117 . 本站查看
5. 刘慧,梁婧,谷学兰,陶洪,武琳琳,龙海灯. 2型糖尿病合并高血压患者血清同型半胱氨酸水平与肾功能和颈动脉粥样硬化的相关性分析. 现代生物医学进展. 2022(04): 766-769+790 . 百度学术
6. 王小荣. 老年隐匿性高血压患者超敏C反应蛋白、尿蛋白、脑钠肽及脉搏波传导速度的关系. 中国医药指南. 2021(10): 64-65 . 百度学术
7. 宫庭. 马来酸依那普利片联合松龄血脉康胶囊治疗老年高血压的研究. 实用医技杂志. 2021(08): 976-978 . 百度学术
8. 林佩莉,杨华婷. 比索洛尔对原发性高血压合并收缩性心力衰竭患者心功能及氧化应激的影响. 海峡药学. 2021(09): 81-84 . 百度学术
9. 王成科,朱欢,董徽徽,胡庆华,胡江平,肖哲,刘晓丽. 运动对高血压患者微血管反应性的干预效应及可能机制研究进展. 中国预防医学杂志. 2021(09): 726-731 . 百度学术
其他类型引用(2)
计量
- 文章访问数: 308
- HTML全文浏览量: 148
- PDF下载量: 38
- 被引次数: 11